A novel small-form NEDD4 regulates cell invasiveness and apoptosis to promote tumor metastasis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Metastasis determinants in hepatocellular carcinoma (HCC) are not fully understood.
• Identifying genes associated with HCC metastasis is crucial for understanding disease progression.

Purpose of the Study:

• To identify novel metastasis-associated genes in hepatocellular carcinoma (HCC).
• To investigate the role of small Neural precursor cell-expressed developmentally downregulated 4 (sNEDD4) in HCC metastasis and prognosis.

Main Methods:

• Generation of highly metastatic HCC cells (SKM) using Transwell assays and mouse models.
• Microarray analysis to identify differentially expressed genes between SKM and parental SK cells.
• Confirmation of sNEDD4 as a novel transcript via liquid chromatography-mass spectrometry.
• In vivo studies using subcutaneous and orthotopic mouse models to assess tumor growth and metastasis.
• Analysis of clinical HCC specimens to correlate sNEDD4 expression with patient prognosis.

Main Results:

• Small Neural precursor cell-expressed developmentally downregulated 4 (sNEDD4) was identified as significantly overexpressed in highly metastatic HCC cells (SKM).
• sNEDD4 overexpression was confirmed in clinical HCC specimens and identified as a poor prognostic factor for male patients.
• In vivo studies demonstrated that sNEDD4 promotes tumor growth, enhances metastasis, increases invasion via matrix metalloproteinase 9 upregulation, and inhibits apoptosis via myeloid cell leukemia 1 upregulation.

Conclusions:

• sNEDD4 is a novel metastasis-associated gene in hepatocellular carcinoma (HCC).
• sNEDD4 promotes tumor growth and metastasis by increasing invasion and inhibiting apoptosis under nutrient-restricted conditions.
• sNEDD4 holds significant potential as a prognostic biomarker for HCC, particularly in male patients.